CD4 and tuberculosis: However, our results indicate that the deletion of CXCR3 resulted in enhanced antigen-specific CD4+ T cell responses to rIAV immunization in the lungs, suggesting that the presence of CXCR3 signalling is not wholly beneficial in the context of mucosal TB vaccination.